Although Meningococcal Meningitis B is rare, for those infected potential serious sequelae loom large and heavy. Fortunately, options for prevention are finally available. October 29th, 2014 the FDA approved the first MenB vaccine, Trumenba through an accelerated process due to a break-through therapy designation. The link below is reporting the University of Oregon cases, however this isn’t the only university campus with recent MenB cases. http://outbreaknewstoday.com/university-of-oregon-hold-meningitis-b-vaccination-clinics-through-march-5-14353/